California study of Ablation (CAABL):early utilization after index hospitalization for non-valvular atrial fibrillation
Autor: | Uma N Srivatsa, Yingbo Yang, Richard H. White, Ezra A. Amsterdam, Nayereh G Pezeshkian, Dali Fan, Beate Danielsen |
---|---|
Rok vydání: | 2017 |
Předmět: |
medicine.medical_specialty
business.industry Medical record medicine.medical_treatment Catheter ablation Atrial fibrillation Emergency department 030204 cardiovascular system & hematology medicine.disease Ablation 03 medical and health sciences 0302 clinical medicine Refractory Internal medicine Ambulatory Epidemiology Cardiology medicine 030212 general & internal medicine Cardiology and Cardiovascular Medicine business Original Research |
Zdroj: | Journal of Atrial Fibrillation. 10 |
ISSN: | 1941-6911 |
DOI: | 10.4022/jafib.1599 |
Popis: | Background Catheter ablation (ABL) for non-valvular AF (NVAF) is recommended for symptomatic patients refractory to medical therapy and its success is related to the duration of the arrhythmia prior to intervention.Our aim was to assess the early utilization and the factors that prompted ABL in patients hospitalized for new onset NVAF. Methods Using de-identified administrative discharge records for hospitalizations and emergency department (ED) visits, we determined the patients who had a first-time (since 1991) health record diagnosis of AF between2005 - 2011. We linked ambulatory surgery encounters for ABL based on ICD 9 code occurring within two years of initial hospitalization. After excluding other cardiac arrhythmias, atrio-ventricular nodal ablation or pacemaker/defibrillator placement and cardiac valve disease, bivariate comparisons were made with those who did not undergo ABL. Results During the study period,3,440 of 424,592 patients (0.81%) hospitalized for new onset NVAF underwent ABL. Parameters significantly (p |
Databáze: | OpenAIRE |
Externí odkaz: |